OMGA
Price:
$0.1426
Market Cap:
$7.90M
Omega Therapeutics, Inc. functions as a biopharmaceutical firm in its development phase. Its innovative OMEGA Epigenomic Programming platform leverages epigenetics—nature's fundamental system for gene regulation and cell differentiation—to engineer therapeutic solutions. The company is advancing various omega epigenomic controller (OEC) candidates to tackle a spectrum of diseases. These candidates are designed to enhance the expression of HNF4a, a crucial transcriptional master regulator, aiming to restore liver cell function in patients with chronic liver ailments. They also work to promote corneal regeneration in those with diabetes and other conditions by regulating genes associated with ...[Read more]
Industry
Biotechnology
IPO Date
2021-07-30
Stock Exchange
NASDAQ
Ticker
OMGA
According to Omega Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -118.82%. This represents a change of 65.00% compared to the average of -72.02% of the last 4 quarters.
The mean historical ROE of Omega Therapeutics, Inc. over the last ten years is -40.19%. The current -118.82% ROE has changed 195.66% with respect to the historical average. Over the past ten years (40 quarters), OMGA's ROE was at its highest in in the March 2020 quarter at 58.82%. The ROE was at its lowest in in the September 2024 quarter at -142.46%.
Average
-40.19%
Median
-34.47%
Minimum
-167.93%
Maximum
51.59%
Discovering the peaks and valleys of Omega Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 180.95%
Maximum Annual ROE = 51.59%
Minimum Annual Increase = -173.77%
Minimum Annual ROE = -167.93%
| Year | ROE | Change |
|---|---|---|
| 2023 | -167.93% | 73.39% |
| 2022 | -96.85% | 180.95% |
| 2021 | -34.47% | -173.77% |
| 2020 | 46.73% | -9.42% |
The current ROE of Omega Therapeutics, Inc. (OMGA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-99.75%
5-year avg
-40.19%
10-year avg
-40.19%
Omega Therapeutics, Inc.’s ROE is greater than Tvardi Therapeutics, Inc. (-64.17%), greater than Turnstone Biologics Corp. (-136.68%), greater than Channel Therapeutics Corporation (-164.11%), less than Biora Therapeutics, Inc. (121.86%), greater than COSCIENS Biopharma Inc. (-13.16%), greater than TNF Pharmaceuticals, Inc. (-59.95%), less than Kineta, Inc. (26.26%), greater than Entero Therapeutics, Inc. (-18.69%), greater than IMV Inc. (-495.17%), greater than Fresh Tracks Therapeutics, Inc. (-66.50%),
| Company | ROE | Market cap |
|---|---|---|
| -64.17% | $24.77M | |
| -136.68% | $8.21M | |
| -164.11% | $8.90M | |
| 121.86% | $994.99K | |
| -13.16% | $8.57M | |
| -59.95% | $9.18M | |
| 26.26% | $7.05M | |
| -18.69% | $13.58M | |
| -495.17% | $23.42K | |
| -66.50% | $5.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Omega Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Omega Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Omega Therapeutics, Inc.'s ROE?
How is the ROE calculated for Omega Therapeutics, Inc. (OMGA)?
What is the highest ROE for Omega Therapeutics, Inc. (OMGA)?
What is the 3-year average ROE for Omega Therapeutics, Inc. (OMGA)?
What is the 5-year average ROE for Omega Therapeutics, Inc. (OMGA)?
How does the current ROE for Omega Therapeutics, Inc. (OMGA) compare to its historical average?